JOSEPH CLERISME: Open Payments
NPI 1790721710 · QUEENS VILLAGE, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,426 in 19 payments from 10 companies in 2025. Trend: 2023 $943 · 2024 $803 · 2025 $1,426
Food & beverage: $1,342Education: $84
| Company | Payments | Amount |
|---|---|---|
| E.R. Squibb & Sons, L.L.C. | 4 | $405 |
| Janssen Pharmaceuticals, Inc | 2 | $150 |
| Neurocrine BioSciences, Inc. | 1 | $138 |
| Luye Pharma (USA) Ltd. | 1 | $130 |
| Phathom Pharmaceuticals, Inc. | 1 | $125 |
| Gilead Sciences, Inc. | 1 | $119 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $119 |
| Alkermes, Inc. | 4 | $102 |
| Teva Pharmaceuticals USA, Inc. | 1 | $78 |
| Otsuka America Pharmaceutical, Inc. | 3 | $61 |
Products named: COBENFY, SPRAVATO, INGREZZA, ERZOFRI EXTENDED-RELEASE, VOQUEZNA, Livdelzi, ARISTADA, ABILIFY ASIMTUFII.
Industry payments across NY — which companies pay providers there.
